New Product Launches by the Key Players Operating in the Market to Boost the Demand for Global Internal Analgesic Tablet Market

The global internal analgesic tablet market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The factors that drive the market include technological advancement, enhancing research and development activities, and growing awareness of various types of analgesics. For instance, in August 2021, Dr. Reddy’s Laboratories announced the re-launched of over-the-counter Naproxen Sodium Tablets USP, 220 mg in the US market. The drug is the store-brand equivalent of Bayer HealthCare’s Aleve. It is used as a pain relief. In August 2020, Arjuna Natural launched Rhuleave-K, a proprietary botanical formula clinically validated to provide safe pain relief with efficacy and speed equivalent to common OTC medications such as acetaminophen (paracetamol). Rhuleave-K is a high-dissolution liquid formulation containing turmeric (Curcuma longa) and frankincense (Boswellia serrata resinous extract) in a black sesame oil basis. To provide immediate treatment of acute musculoskeletal pain, the three botanicals are synergistically mixed with a proprietary technology. Several investigations have confirmed the analgesic effectiveness of B. serrata extract, particularly its beneficial effect on joint tenderness in osteoarthritis patients. In comparison to placebos, it has also shown to be able to raise the pain threshold. These two components have the potential to block a variety of pain channels, including COX-2 (cyclooxygenase) and LOX (lipoxygenase) receptors. The company uses a new SPEED delivery system that ensures the actives are dispersed quickly and uniformly, supporting the company's fast-action mechanism. Black sesame oil functions as a carrier, dispersing and dissolving fat-soluble substances in the body.

Browse the full report description “Global Internal Analgesic Tablet Market Size, Share & Trends Analysis Report by Type (Central Painkiller, Narcotic Analgesics, Antispasmodic Painkillers, Anxiolytic Analgesic, and Others), By Application (Home Use, Hospital, Clinic and Other) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/internal-analgesic-tablet-market

However, strict regulatory practices and the increasing cost of branded drugs are some of the restrainting factors in the internal analgesic tablet market. Additionally, the advancement treatment choices and the basic availability of healthcare facilities are propelling the growth of internal analgesic tablet market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Type
• By Application

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- including the Bayer AG, GlaxoSmithKline plc, Johnson & Johnson Consumer Inc., and others

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Internal Analgesic Tablet Market Report Segment

By Type

• Central Painkiller
• Narcotic Analgesics
• Antispasmodic Painkillers
• Anxiolytic Analgesic
• Others

By Application

• Home Use
• Hospital
• Clinic
• Other

Global Internal Analgesic Tablet Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/internal-analgesic-tablet-market